Biosynthesis of Tasikamides via Pathway Coupling and Diazonium-Mediated Hydrazone Formation

Guang-Lei Ma,Hartono Candra,Li Mei Pang,Juan Xiong,Yichen Ding,Hoa Thi Tran,Zhen Jie Low,Hong Ye,Min Liu,Jie Zheng,Mingliang Fang,Bin Cao,Zhao-Xun Liang
DOI: https://doi.org/10.1021/jacs.1c10369
IF: 15
2022-01-21
Journal of the American Chemical Society
Abstract:Naturally occurring hydrazones are rare despite the ubiquitous usage of synthetic hydrazones in the preparation of organic compounds and functional materials. In this study, we discovered a family of novel microbial metabolites (tasikamides) that share a unique cyclic pentapeptide scaffold. Surprisingly, tasikamides A-C (<b>1</b>-<b>3</b>) contain a hydrazone group (C═N─N) that joins the cyclic peptide scaffold to an alkyl 5-hydroxylanthranilate (AHA) moiety. We discovered that the biosynthesis of <b>1</b>-<b>3</b> requires two discrete gene clusters, with one encoding a nonribosomal peptide synthetase (NRPS) pathway for assembling the cyclic peptide scaffold and another encoding the AHA-synthesizing pathway. The AHA gene cluster encodes three ancillary enzymes that catalyze the diazotization of AHA to yield an aryl diazonium species (diazo-AHA). The electrophilic diazo-AHA undergoes nonenzymatic Japp-Klingemann coupling with a β-keto aldehyde-containing cyclic peptide precursor to furnish the hydrazone group and yield <b>1</b>-<b>3</b>. The studies together unraveled a novel mechanism whereby specialized metabolites are formed by the coupling of two biosynthetic pathways <i>via</i> an unprecedented <i>in vivo</i> Japp-Klingemann reaction. The findings raise the prospect of exploiting the arylamine-diazotizing enzymes (AAD) for the <i>in vivo</i> synthesis of aryl compounds and modification of biological macromolecules.
chemistry, multidisciplinary
What problem does this paper attempt to address?